Nutrient sachets may boost vaccination rates in rural africa

NCT ID NCT07592260

First seen May 19, 2026 · Last updated Jun 19, 2026 · Updated 5 times

Summary

This study in Chad and Niger tests whether giving a small, nutrient-packed food supplement (SQ-LNS) to children aged 6 to 11 months can encourage families to complete routine vaccinations. Around 20,000 children will receive the supplement until they are 18 months old, and researchers will compare vaccination rates to areas without the program. The goal is to break the cycle of malnutrition and infectious disease by improving both nutrition and immunization coverage.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALNUTRITION SEVERE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mirriah hospital

    RECRUITING

    Mirriah, Zinder Region, 70004, Niger

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ngouri hospital

    RECRUITING

    Ngouri, Lac Region, 00000, Chad

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

small quantity lipid-based nutritional supplement (SQ-LNS)

What this could lead to

If successful, this approach could provide a simple, low-cost way to boost childhood vaccination coverage and reduce severe malnutrition in vulnerable communities.

What could go wrong

This is a large but early-stage field study; real-world challenges like supply chains, community acceptance, and measuring true vaccination impact may limit results.

Conditions

The condition(s) this trial relates to.

nutritional deficiency disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.